Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease
M Aardoom, Gigi Veereman, Lissy de Ridder
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2529-2529
Open Access | Times Cited: 93

Showing 51-75 of 93 citing articles:

From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)
Samaneh Tavassoli, Iman Shahabinasab, Alireza Norouzi, et al.
BMC Musculoskeletal Disorders (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Study on the Effective Material Basis and Mechanism of Traditional Chinese Medicine Prescription (QJC) Against Stress Diarrhea in Mice
Yuefeng Zhang, Fei Yu, Jingyou Hao, et al.
Frontiers in Veterinary Science (2021) Vol. 8
Open Access | Times Cited: 7
Optimizing Antitumor Necrosis Factor Treatment in Pediatric Inflammatory Bowel Disease With Therapeutic Drug Monitoring
Isabel Pinto Pais, Maria C. Espinheira, Eunice Trindade, et al.
Journal of Pediatric Gastroenterology and Nutrition (2020) Vol. 71, Iss. 1, pp. 12-18
Open Access | Times Cited: 7
Establishment of a lipopolysaccharide-induced inflammation model of human fetal colon cells
Keqi Yu, Shengtao Liao, Chuanfei Li, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 5557-5564
Open Access | Times Cited: 2
Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine
Federica Giachero, Andreas Jenke, Matthias Zilbauer
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 8, pp. 871-881
Open Access | Times Cited: 6
Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
Sara Salvador‐Martín, Alejandra Melgarejo-Ortuño, Luis A. López‐Fernández
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1786-1786
Open Access | Times Cited: 6
PERFUSE: Non-Interventional Cohort Study of Patients Receiving Infliximab Biosimilar SB2: Results in Pediatric Patients
Christine Martinez‐Vinson, A. Lemoine, Yoram Bouhnik, et al.
Journal of Pediatric Gastroenterology and Nutrition (2022) Vol. 76, Iss. 4, pp. 451-459
Open Access | Times Cited: 4
Evaluation of adalimumab effects on left ventricle performance by echocardiography indexes among patients with immunosuppressant refractory ulcerative colitis
Mohammad Reza Hatamnejad, Mersedeh Karvandi, Fateme Jodatfar, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 2
One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study
Stefania Cheli, Diego Savino, Annalisa De Silvestri, et al.
The Pharmacogenomics Journal (2023) Vol. 23, Iss. 5, pp. 112-118
Open Access | Times Cited: 2
Generating Bone Marrow Chimeric Mouse Using GPR120 Deficient Mouse for the Study of DHA Inhibitory Effect on Osteoclast Formation and Bone Resorption
Jinghan Ma, Hideki Kitaura, Fumitoshi Ohori, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17000-17000
Open Access | Times Cited: 2
Screening and experimental validation of diagnostic gene in ulcerative colitis with anti‐TNF‐α therapy
Chen Yuan, Xinfang Li, Ran Sun, et al.
IUBMB Life (2024) Vol. 76, Iss. 7, pp. 451-463
Closed Access
Posttranscriptional Events Orchestrate Immune Homeostasis of CD8+ T Cells
Julian J. Freen‐van Heeren
Methods in molecular biology (2024), pp. 65-80
Closed Access
PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model
Jessica Codesido, Lara García-Varela, Xurxo García‐Otero, et al.
International Journal of Pharmaceutics (2024), pp. 125011-125011
Closed Access
Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a real-world analysis from FAERS database
Yanhong Deng, Shengying Shi, Senling Feng, et al.
Research Square (Research Square) (2024)
Open Access
Comparison of three immunoassays for infliximab trough level monitoring in paediatric inflammatory bowel diseases
Juliette Villemonteix, Valérie Guérin‐El Khourouj, Jean‐Pierre Hugot, et al.
Biologicals (2021) Vol. 70, pp. 17-21
Closed Access | Times Cited: 4
Anti-TNF Therapies Other Than Infliximab for the Treatment of Pediatric Inflammatory Bowel Disease
Stephanie Gold, Louis Cohen
Springer eBooks (2023), pp. 423-443
Closed Access | Times Cited: 1
Novel mRNA Signature for Anti-TNF-α Therapy Primary Response in Patients With Ulcerative Colitis
Xinhui Yang, Jintong Shi, Gaoyang Wang, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 9, pp. 1458-1469
Closed Access | Times Cited: 1
Clinical and Diagnostic Value of Inflammatory Bowel Diseases' Serological Markers in Children (Literature Review)
А. А. Камалова, Marina A. Khanafina, Galina Alekseevna Garina
Педиатрическая фармакология (2023) Vol. 20, Iss. 4, pp. 309-317
Open Access | Times Cited: 1
The Effect of Serotonin Transmission on Depressive and Insomnia Symptoms in Inflammatory Bowel Diseases
Marcin Sochal, Alicja Witkowska, Agata Binienda, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6353-6353
Open Access | Times Cited: 1
The Dynamic Crosstalk between Gut Microbiota, Immune System, and Autophagy in the Onset of Inflammatory Bowel Disease: Molecular Mechanisms and Current Therapeutic Approaches
Beatrice Garavaglia, Letizia Vallino, Angela Amoruso, et al.
(2023)
Open Access | Times Cited: 1
Pharmacogenetic Effect of Thiopurine Methyl Transferase (TPMT) Gene Expression and Serum TNF on the Imuran Response in Ulcerative Colitis (UC) Iraqi Patients
Noor Rasidah Ali, Rafid A. Abdulkareem
Reports of Biochemistry and Molecular Biology (2023) Vol. 12, Iss. 3, pp. 438-447
Open Access | Times Cited: 1
Golimumab in adolescents with Crohn's disease refractory to previous tumour necrosis factor antibody
Judith Pichler, Nima Memaran, Wolf Dietrich Huber, et al.
Acta Paediatrica (2020) Vol. 110, Iss. 2, pp. 661-667
Open Access | Times Cited: 3
Running Behind “POPO”—Impact of Predictors of Poor Outcome for Treatment Stratification in Pediatric Crohn's Disease
Jan de Laffolie, Klaus‐Peter Zimmer, Keywan Sohrabi, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 3
Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis
Marouf Alhalabi, Kamal Alaa Eddin, Khaled Cheha, et al.
Medicine (2021) Vol. 100, Iss. 38, pp. e27283-e27283
Open Access | Times Cited: 3
Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease
Johanna Lehtomäki, Anne Nikkonen, Laura Merras‐Salmio, et al.
Scandinavian Journal of Gastroenterology (2021) Vol. 57, Iss. 1, pp. 31-36
Open Access | Times Cited: 3

Scroll to top